The profound impact of artificial intelligence on medicine and scientific research is now undeniably clear, transforming fields once thought impenetrable by algorithms. This pivotal shift was a central theme on a recent Forward Future Live broadcast where hosts Matt and Nick discussed the latest advancements in AI with Dr. Derya Unutmaz, MD, a distinguished professor at the Jackson Laboratory, alongside other industry leaders.
Before diving into Dr. Unutmaz's specialized insights, the hosts unpacked several noteworthy developments. NVIDIA's recent Q3 revenue report, while impressive, was met with a muted investor response, with the stock dipping post-earnings. Matt and Nick questioned whether this indicated market saturation, geopolitical concerns regarding China, or simply a growing investor fatigue with "financial engineering" tactics like NVIDIA's approved $60 billion share buyback, contrasting it with the demand for tangible innovation in new fabs and R&D.
